Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion type Assertion NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_head.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion wasGeneratedBy ECO_0000203 NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion wasDerivedFrom befree-2016 NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion SIO_000772 25724664 NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion evidence source_evidence_literature NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion description "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.